We also know that cannabis (CBD in particular) is a powerful anti-inflammatory. This medical article titled “The Endocannabinoid System and Plant-Derived Cannabinoids in Diabetes and Diabetic Complications” is good place to learn about this and from a highly reputable and reliable source.
My article this month is on cannabis as a treatment for diabetes and you are encouraged to read that article. So that brings us back to our case study this month and why we chose it.
From the onset, we have encouraged investors to consider diversification and that includes companies within the industry that have diversified business lines and revenue channels. We were also one of the first (if not the first) to highlight that it was time to look at companies with US operations as well as large companies looking to enter the cannabis space and that is the focus of Case Study #2.
Consellation Btands (STZ) and Canopy Growth (CGC) comes to mind and we were again one of the first, if not the first, to draw attention to Alliance One International (AOI) which has since changed its name and stock symbol to Pyxus International Inc (PYX) as well as to look at Scott’s MiracleGro (SMG).
Although we bring your attention to specific companies each month in addition to industry leading stock lists, our focus has always been to remind you that the ROI is ancillary. In other words, an industry with such growth potential that could also change forever how we will live will ultimately reward investors.
How does MNKD fit into any of this?
First of all, MNKD’s technology is an inhaler based delivery system. According to its website:
Afrezza is the only rapid
acting insulin available that can be inhaled. Other mealtime insulin options are delivered through injection. Afrezza can potentially save you about 1,000 needle
sticks per year.
Diabetes is being referred to as a modern epidemic and in fact just may be the biggest epidemic of the 21st Centurty.
I think you already see where this is going … we know that the the Endocannabinoid System provides an important role in blood glucose Endocannabinoid System provides an important role in blood glucose moderating and there is further research underway. We also know that MNKD has a potentially game changing delivery system for its FDA approved Afreeza.
309